GGrantIndex
Sort

51,593 grants matching hepatitis

Determinants of the racial/ethnic disparity in MGUS risk: An epidemiologic study in 4 cohorts

$975,742
Wendy Cozen · University Of California-Irvine · R01 · FY2021 · CA

Role of inflammation, innate resistance, and immunity in carcinogenesis.

$975,704
Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

MOLECULAR EPIDEMIOLOGY OF HEPATOCELLULAR CARCINOMA

$974,950
Fox Chase Cancer Center · U19 · FY2002 · CA

DRIVE (DRug use and blood-borne Infections in ViEtnam): Combined prevention and care to end the HIV epidemic among people who inject drugs in Haiphong, Viet Nam

$974,658
Don C Des Jarlais · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · DA

Hepatic Clearance Chip for Pharmacokinetics

$974,458
Murat Cirit · Javelin Biotech · R44 · FY2024 · TR

A Novel Recombinant Protein for Mitigating Acute Radiation Injury

$974,383
Wayne Chaung · Therasource, Llc · R44 · FY2021 · AI

A Novel Recombinant Protein for Mitigating Acute Radiation Injury

$974,383
Wayne Chaung · Therasource, Llc · R44 · FY2022 · AI

A Novel Recombinant Protein for Mitigating Acute Radiation Injury

$974,383
Wayne Chaung · Therasource, Llc · R44 · FY2020 · AI

Case Proteomics Center for HIV/AIDS and Drug Abuse

$974,149
Mark R Chance · Case Western Reserve University · P20 · FY2011 · DA

ENZYMIC ACTIVATION OF CHEMICAL CARCINOGENS

$974,023
Vanderbilt University · R35 · FY2000 · CA

Molecular Approaches To Antiviral and Vaccine Development For Hepatitis C

$973,984
T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2015 · DK

Studies of HCV Infection And HCV-Host interactions

$973,984
T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2015 · DK

NIDA Clinical Trials Network: Greater New York Node

$973,826
John P Rotrosen · New York University School Of Medicine · UG1 · FY2019 · DA

Postmortem Pathology

$973,411
David E Kleiner · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA

NCI ET-CTN with Phase i Emphasis at UPCI

$973,400
Edward Chu · University Of Pittsburgh At Pittsburgh · UM1 · FY2016 · CA

Childhood Liver Disease Research Network Data Coordinating Center

$973,076
John C Magee · University Of Michigan At Ann Arbor · U01 · FY2018 · DK

Individual, Network and Spatial Drivers of HIV and HCV among PWID in India

$972,068
Sunil Suhas Solomon · Johns Hopkins University · R01 · FY2021 · DA

Candidate selection of a LPAR1 antagonist for therapeutic application in NASH

$971,732
Fabio Cohen Tucci · Epigen Biosciences, Inc. · R44 · FY2023 · DK

Small molecule targeting viral nucleotidyltransferases

$971,722
Stuart F. J. Le Grice · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Structural Biology Of Virus Assembly

$971,514
Paul T Wingfield · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2019 · AR

A Novel Therapeutic for Liver Fibrosis

$971,501
Prakash Narayan · Angion Biomedica Corporation · R44 · FY2012 · AA

ERC Einstein Rockefeller CUNY Center for AIDS Research

$971,403
Vinayaka R Prasad · Albert Einstein College Of Medicine · P30 · FY2023 · AI

Chemical Stabilization of shRNAs and their development as hepatitis C drugs

$970,401
Brian H. Johnston · Somagenics, Inc. · R44 · FY2012 · AI

Genetics, Natural History, and Pathophysiology of Behcet's Disease

$969,882
Daniel Kastner · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2010 · AR

CENTER FOR GASTROINTESTINAL BIOLOGY AND DISEASE

$969,828
Robert S Sandler · Univ Of North Carolina Chapel Hill · P30 · FY2007 · DK